Using PuraStat® with Adrenaline for treating upper gastrointestinal bleeding

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial evaluates the effectiveness of PuraStat®, a novel hemostatic gel, combined with Adrenaline compared to standard care in managing upper gastrointestinal bleeding (UGIB). The study aims to determine if this combination can provide better outcomes in terms of hemostasis and reduce re-bleeding rates. Participants will undergo endoscopic therapy, and the trial will assess the safety and efficacy of the treatment approach. The study is designed as a prospective, randomized, parallel-group, open-label trial.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Age \>18 years
* Undergoing endoscopic therapy for non-variceal gastrointestinal bleeding

Exclusion Criteria:

* Variceal or portal hypertension-related gastrointestinal bleeding
* Lack of signed consent form
* Pregnancy or breastfeeding

Where it's running

• Hospital Arnau de Vilanova de Lleida
  Lleida, Spain Recruiting

Study contacts

• Study coordinator: Raquel Ballester
• Email: rballester.lleida.ics@gencat.cat
• Phone: 973705342

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Comparing OTSC and Angiographic Embolization for Severe Upper Gastrointestinal Bleeding

  This study is testing whether a new clip treatment can work as well as a traditional procedure for stopping severe bleeding in the stomach and intestines for patients with certain types of bleeding.

  Recruiting at 5 sites Chinese University of Hong Kong · Beijing, Beijing Municipality and 4 other locations · NCT04902248

• Testing the Glasgow-Blatchford bleeding score in Tunisian adults with upper gastrointestinal bleeding

  This project will see if the Glasgow‑Blatchford Score can predict 30‑day complications in adults in Tunisia who come to the emergency department with non‑traumatic upper gastrointestinal bleeding.

  Recruiting Hôpital Universitaire Sahloul · Sousse · NCT07089277

• Using Tranexamic Acid and Vitamin K to Treat Upper Gastrointestinal Bleeding in Cirrhotic Patients

  This study is testing whether giving Tranexamic acid and vitamin K can help control bleeding in the stomach for people with liver cirrhosis.

  Recruiting Phase 4 Tanta University · Tanta, Gharbyea · NCT06881628

• Carbon footprint of diagnostic versus therapeutic upper GI endoscopy

  This project will measure how much carbon is produced by diagnostic endoscopy for dyspepsia compared with therapeutic endoscopy for non-variceal upper GI bleeding.

  Recruiting at 2 sites King Chulalongkorn Memorial Hospital · Bangkok and 1 other locations · NCT07261228

• Predicting rebleeding risk in patients with acute gastrointestinal bleeding

  This study is trying to create a better way to predict which patients who have had serious stomach bleeding are at risk of bleeding again, so doctors can provide better care and prevention.

  Recruiting Wuhan Central Hospital · Wuhan, Hubei · NCT06697691

• Endovascular treatment outcomes after portal hypertension–related GI bleeding in cirrhosis

  This study tests how well endovascular procedures for portal hypertension–related GI bleeding work in adults with cirrhosis, and what factors predict outcomes.

  Recruiting University Medical Center Ho Chi Minh City (UMC) · Ho Chi Minh City · NCT07918378

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.